
Vaxfab Enterprises Faces Intense Selling Pressure Amidst Consecutive Losses
2025-12-05 11:36:05Vaxfab Enterprises Ltd is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers in the queue. This extreme selling activity signals distress among investors, as the company’s shares continue to face downward momentum amid a series of consecutive losses over recent weeks.
Read More
Vaxfab Enterprises Faces Intense Selling Pressure Amidst Consecutive Losses
2025-12-04 13:26:10Vaxfab Enterprises Ltd is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers in the market. This distress selling has resulted in a notable decline in the share price, reflecting a challenging trading session for the company within the Trading & Distributors sector.
Read More
Vaxfab Enterprises Sees Extraordinary Buying Interest Amid Upper Circuit Scenario
2025-11-28 12:26:08Vaxfab Enterprises has captured market attention with an extraordinary surge in buying activity, registering consecutive gains and trading exclusively with buy orders in the queue. This unusual market behaviour suggests a potential multi-day upper circuit scenario, underscoring strong investor interest in the Trading & Distributors sector.
Read More
Vaxfab Enterprises Sees Unprecedented Buying Interest, Edges Towards Multi-Day Upper Circuit
2025-11-27 15:20:41Vaxfab Enterprises has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an order book dominated exclusively by buy orders. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, underscoring the stock’s remarkable performance relative to broader indices and its sector peers.
Read More
Vaxfab Enterprises Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-21 13:25:51Vaxfab Enterprises Ltd has encountered significant selling pressure today, with the stock registering a decline of 1.99% and exhibiting a complete absence of buyers in the queue. This development follows three consecutive days of gains, signalling a notable shift in market sentiment for the trading and distributors sector player.
Read More
Vaxfab Enterprises Surges with Unprecedented Buying Interest and Upper Circuit Momentum
2025-11-20 11:21:30Vaxfab Enterprises Ltd has captured market attention with extraordinary buying interest, registering an upper circuit scenario marked by an absence of sellers. The stock’s performance outpaces the broader Sensex and sector benchmarks, signalling robust investor enthusiasm and the potential for a sustained multi-day circuit run.
Read More
Vaxfab Enterprises Hits Upper Circuit Amidst Unprecedented Buying Interest
2025-11-19 10:36:10Vaxfab Enterprises Ltd has surged to an upper circuit with only buy orders in the queue, reflecting extraordinary buying interest and a complete absence of sellers. This rare market phenomenon signals a potential multi-day circuit scenario, underscoring the stock’s remarkable momentum in the Trading & Distributors sector.
Read More
Vaxfab Enterprises Ltd Surges 1.99% Today, Gains 254.59% Year-to-Date Amid Strong Buying Activity
2025-11-18 11:31:30Vaxfab Enterprises Ltd is experiencing a surge in buying activity, reversing a five-day decline. The stock has shown significant growth over various time frames, outperforming the Sensex. Today's trading session opened positively, with the stock maintaining positions above several moving averages, reflecting strong market interest.
Read MoreIs Vaxfab Enterp. overvalued or undervalued?
2025-11-18 08:25:58As of 17 November 2025, Vaxfab Enterprises has moved from a fair to a very attractive valuation grade. The company is currently considered undervalued, supported by a PE ratio of 4.69, an EV to EBIT of 3.44, and a remarkable ROCE of 61.79%. In comparison to peers, Vaxfab's valuation metrics stand out significantly; for instance, Elitecon International has a PE ratio of 294.38, while PTC India, another attractive peer, has a PE ratio of 7.56. The company's strong performance is further underscored by its PEG ratio of 0.02, indicating substantial growth potential relative to its price. Despite a recent dip in stock price, Vaxfab has demonstrated impressive returns year-to-date at 247.66%, significantly outperforming the Sensex's 8.72% during the same period. Overall, the compelling valuation ratios and robust performance metrics suggest that Vaxfab Enterprises is indeed undervalued in the current market....
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
02-Dec-2025 | Source : BSEIntimation of Notice of 2nd EOGM of the Company of FY 2025-26 in the Newspaper
Second EGM Of The Company For The FY 2025-26 Will Be Held On 27-12-2025 Saturday At 11:00 A.M.
01-Dec-2025 | Source : BSESecond EGM of the Company for the FY 2025-26 will be held on 27-12-2025 Saturday at 11:00 A.M
Board Meeting Outcome for Outcome Of Board Meeting
01-Dec-2025 | Source : BSEAs Attached
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Vaxfab Enterprises Ltd has announced 6:1 rights issue, ex-date: 03 Jan 23






